Viral hepatitis is a global public health concern, with an estimated 325 million individuals worldwide living with hepatitis B virus (HBV) and hepatitis C virus (HCV) infection. This learning activity reviews the role of antiviral therapy as the cornerstone of chronic hepatitis B (CHB) and C (CHC) management.
Upon completing this module,participants will have a better understanding of the following aspects:
• Epidemiology and burden of disease
• Clinical manifestations and diagnosis of viral hepatitis
• Antiviral therapy
• Screening for hepatocellular carcinoma (HCC)
Professor Dr Lee Yeong Yeh
Consultant Gastroenterologist and Hepatologist
Universiti Sains Malaysia
Please read thoroughly & understand the module before attempting the assessment questions.
Terms & Conditions:
■ Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point.
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points.
The modules/articles are best viewed with:
Google Chrome, Firefox, Internet Explorer, Safari or any other W3C standards compliant browsermay be required to view the modules.